... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ether > aromatic ether > 3-Propyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ether > aromatic ether > 3-Propyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ether > aromatic ether > 3-Propyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > aromatic compound > organic aromatic compound > aromatic ether > 3-Propyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > aromatic ether > 3-Propyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine

... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > aromatic ether > 3-Propyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > aromatic ether > 3-Propyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine